Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07228468 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Home-Based Transcranial Direct Current Stimulation In Major Depressive Disorder (HOME)

Study acronym: HOME
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Eligibility criteria revisedv3
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 4, 2025 to Nov 18, 2025
    • Site details revised at 6 of 6 sites
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
3,055 trials monitored
See 173 trials at risk
Depression is a prevalent and debilitating disorder. The most common treatments are antidepressant medications and talking therapies. However, for many individuals, these are not their treatment of choice. Furthermore, even following a full course of treatment with an antidepressant or talking therapy, over one third of patients continue to be unwell. The novel brain stimulation treatment, transcranial direct current stimulation (tDCS), is a potential first-line treatment for major depression. The present research question is whether home-based tDCS is an effective treatment for major depression for adults with major depression. Participants will be randomised to receive either a 10-week course of active tDCS treatment in addition to their standard care (Treatment as Usual), or to only receive Treatment as Usual. Participants will be followed up for 6-months after the start of the treatment began. After the 6-month follow-up visit, all participants from both groups can choose to continue/start the tDCS treatment. There will be a final follow-up visit 3 months later (9 months from the original treatment start of the trial).
Trial Details
NCT Number NCT07228468
Lead Sponsor King's College London
Collaborators: Nottinghamshire Healthcare NHS Trust, Cardiff and Vale University Health Board, Northumberland, Tyne and Wear NHS Foundation Trust, Northamptonshire Healthcare NHS Foundation Trust, South London and Maudsley NHS Foundation Trust, Southern Health NHS Foundation Trust
Conditions
(from sponsor)
Major Depressive Disorder (MDD)
Related terms Major Depressive Disorder
Enrollment 438 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov